Meitheal Pharmaceuticals Inc: Drug Recall
Recall #D-0286-2021 · 01/27/2021
Class I: Dangerous
Recall Details
- Recall Number
- D-0286-2021
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Meitheal Pharmaceuticals Inc
- Status
- Terminated
- Date Initiated
- 01/27/2021
- Location
- Chicago, IL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 34,860 vials
Reason for Recall
Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium
Product Description
Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06), Rx only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL 60631.
Distribution Pattern
Nationwide USA
Other Recalls by Meitheal Pharmaceuticals Inc
- Class III: Low Risk 09/03/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.